Author: CannabisNewsWire (CNW)

About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) to Commence Trading on the Toronto Stock Exchange; Provides Cannabis 2.0 Update

VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), an Ontario-based cannabis company recognized for its premium products and services, today announced that its common shares are set to start trading on the Toronto Stock Exchange (“TSX”) under the symbol ‘VIVO’ at market open on January 24, 2020. The company’s common shares will be voluntarily delisted from the TSX Venture Exchange in connection with the TSX listing. “The strength of the Toronto Stock Exchange is world-class, and this event represents a tremendous milestone for VIVO,” VIVO Cannabis CEO Barry Fishman stated in the news release. “We believe the TSX listing will increase VIVO’s exposure to a wider audience, increase trading liquidity and expand access to a large new pool of institutional investors.”

In addition, the company provided an update regarding its cannabis 2.0 products. Per the update, VIVO has successfully shipped cannabis 2.0 products from its Canna Farms facility to the provinces of Saskatchewan and Manitoba, and anticipates shipping purchase orders to Alberta, Ontario and British Columbia very soon. Before the end of Q1 2020, VIVO expects to make initial shipments of its Fireside(TM) chocolate products to British Columbia, Alberta, Saskatchewan, Manitoba and Ontario, and its Fireside(TM) concentrates and vape products from its Vanluven facility to Alberta, Ontario, British Columbia and New Brunswick. “We expect that by the end of Q1 2020, our cannabis 2.0 products will be available for sale in seven provinces, which is a significant achievement considering the recent opening of the market,” VIVO Cannabis CEO Barry Fishman stated in the news release. “We are proud of our suite of 2.0 products and look forward to our customers having the opportunity to experience them for themselves.”

To view the full press release visit http://cnw.fm/hL1nb

About VIVO Cannabis(TM)

VIVO, based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine service. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://cnw.fm/VIVO

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Additional Taxes Could Make Illinois Recreational Weed a Lot More Expensive

Marijuana customers in Illinois are in for a price shock come July 1 this year as new taxes take effect. Currently, in Illinois, marijuana sales are being subjected to state and local taxes, plus an additional state marijuana excise tax, which has increased the overall tax rate from 20.25% to 35.25% in the municipalities and counties. This also depends on the potency of marijuana being sold.

The cities and counties in the state are yet to start imposing local weed taxes, which is 3 percent each, and this could drive up the overall tax rate to 41.25%. Of the 11 states where adult-use marijuana is legal, Washington is the only state whose tax rate is higher at 47%.

During the first day of recreational marijuana sales in Illinois, some marijuana customers posted their receipts on social media, which attracted a lot of attention. But, as far as sales are concerned, tax rates didn’t seem to deter the customers.

The supply of recreational marijuana is low and it cannot meet the existing demand. And, it is predicted that the recreational marijuana shortage may be experienced even in 2021 because additional demand for marijuana will come in through online shoppers in the coming months.

The managing director for BDS Analytics, Tom Adams, said that it is exciting going into a marijuana shop for the first time, but the feeling dies off real quick when they start running the numbers in your head, and the demand reduces. BDS Analytics is a research firm that tracks the marijuana sector.

The CEO of MedMen, Adam Bierman, said that the customer’s shopping experience is ruined by the high taxes. MedMen is based in Los Angeles and operates dispensaries located in Evanson and Oak Park.

Tom Adams further said the higher taxes would force people to buy weed from the black market where there are no taxes; thus, the illicit market will continue to grow.

According to BDS Analytics estimates, in Washington, the black markets take up 51% of the total marijuana sales, while in Colorado, where taxes are 25%, the black market accounts for 34%.

Michigan launched its recreational marijuana sales on December 1 last year, and its overall tax is at 16%.

Tax is one of the factors that determine the growth of the legal marijuana market, said Adams.

Because the marijuana shortage in Illinois will not be solved anytime soon, the consumers within the state may not see the effect of the imminent tax increase for a while.

A few months ago, the legislators warned that the tax rates might influence marijuana sales, but since every level of government within the state is struggling financially, they were more focused on the income that would come with legalization.

This year, the state expects to collect $57 million in tax revenue from marijuana sales, which would increase to $141 million for the financial year beginning on July 1. The state of Illinois estimates that within four years, it will have hit $376 in tax revenue.

Industry experts say that it wouldn’t be surprising if companies like Dama Financial and ChineseInvestors.com (OTCQB: CIIX) associated with the cannabis industry recommend a revisiting of the Illinois marijuana tax regime in order to avoid stifling the nascent legal industry.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Arkansas Piles Pressure on Licensed Medical Marijuana Dispensaries to Open

On the morning of January 19, local media outlets published several stories updating the residents of Arkansas on medical marijuana, as the opening of dispensaries continues at a slow pace. Half of the state’s licensed dispensaries are not yet operational and the state is moving to compel them to open or risk losing their licenses.

The Medical Marijuana Commission in Arkansas is planning to meet with all the dispensary owners and marijuana growing companies to discuss and determine whether their licenses should be extended for another year. There are 32 dispensary operators and five cannabis growing companies.

It is one year since the first licenses were issued, and 16 dispensaries are yet to open. The companies that have not opened or made any progress may lose their licenses, the commissioners hinted.

Although voters legalized medical marijuana through the ballot back in 2016, the state has made very little progress. The licenses for medical marijuana dispensaries were issued in 2019, and the first dispensary was opened in May the same year. So far, 16 dispensaries are operational, and they have so far sold 5,000 pounds of marijuana for not less than $33 million. Arkansas residents with medical marijuana cards are about 35,000.

Many operational dispensaries are looking to start growing their own marijuana. The spokesman for the Arkansas Department of Finance and Administration, Scott Hardin, said that the dispensaries are also licensed to cultivate marijuana, but they had opted to start with the shop outlet so that they could become operational faster.

According to some business representatives, many businesses are planning to grow the amount of marijuana permitted by the state, which is 50 mature plants. The dispensaries include Acanza in Fayetteville, The ReLeaf Center in Bentonville, and The Source in Bentonville. Currently, the three businesses are buying cannabis from the three cultivation sites in the state. According to Arkansas law, dispensaries within the state may only purchase marijuana for their shops from the cultivation sites within Arkansas.

Hardin said that when the four dispensaries located in Northwest applied for their licenses, they were approved to add a cultivation location. But because the state must first inspect the cultivation location, the four dispensaries could not begin their cultivation process.

The state of Arkansas is working to establish rules and regulations for dispensaries with cultivation locations so that they can also be allowed to process their marijuana once its harvested.

Analysts believe that the entire cannabis industry, including Lexaria Biosciences Corp. (CSE: LXX) (OTCQX: LXRP), would be glad to see all licensed dispensaries open for business so that the people of Arkansas can have many options to choose from.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Sugarmade, Inc. (SGMD) Places Hold on Reverse Split, Plans Entry into Regulated and Licensed Portion of Cannabis Marketplace

Sugarmade (OTCQB: SGMD) today announced that it has placed a hold on plans to complete a reverse split of its common shares. Per the update, pending a vote by its board of directors, management believes temporarily holding or canceling the reverse split may be the best future course of action. In addition, Sugarmade announced its planned entry into the regulated and licensed portion of the cannabis marketplace, with an emphasis on the California distribution and retail sectors. “For at least the time being, we do not see a reason to move forward with the reverse stock split. However, we reserve the right, should circumstances warrant, to reactivate the reverse,” Sugarmade CEO Jimmy Chan said in the news release. “We are in the process of modifying our business strategy to better align with where the cannabis marketplace is headed and thus our cancellation of the previously proposed transaction. We see significantly larger opportunities in the California cannabis distribution arena and have entered into advanced talks to make a strategic move into this area.”

To view the full press release, visit http://cnw.fm/sn0Ez

About Sugarmade, Inc.

Sugarmade, Inc. (OTCQB: SGMD) is a product and branding marketing company investing in operations and technologies with disruptive potential. For more information, visit the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SUGAR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Provide Patented DehydraTECH(TM) to Cannadips’ Cannabis Products in California and Across the US

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced that it has reached a new definitive agreement to provide its patented DehydraTECH(TM) technology to Cannadips’ cannabis products, both in its current California market and across the United States. According to the update, Lexaria’s DehydraTECH fast-acting, high-absorption technology is perfectly suited to improve consumer satisfaction and the dipping experience. Terpene-rich multi spectrum oils are base ingredients of Cannadips THC, and DehydraTECH is able to reduce throat irritation normally associated with some terpenes. Inferior products utilize less efficacious cannabis isolate without terpenes that lack the entourage effect derived from multi-spectrum oils in an attempt to get around this problem. “Lexaria is building a stronger relationship with the Cannadips brand and applying DehydraTECH to Cannadips cannabis represents our latest advance,” Lexaria Bioscience CEO Chris Bunka stated in the news release. “Our DehydraTECH technology empowers a scalable supply chain across state lines for our cannabis brand licensees. We are excited that Cannadips is interested in activating the Lexaria technology in additional key state markets that are either recreational or medical cannabis states, while preserving the brand rights as states come online through regulation.”

To view the full press release, visit http://cnw.fm/4qN9T

About Lexaria Bioscience Corp.

Lexaria Bioscience is a global innovator in drug-delivery platforms. The company’s patented DehydraTECH drug-delivery technology changes the way active pharmaceutical ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bioabsorption, reduces time of onset and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, nonsteroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products, as well as to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://cnw.fm/LXX

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CannabisNewsBreaks – Grapefruit Boulevard Investments, Inc. (IGNG) Files Amendment No. 1 to Registration Statement

Grapefruit Boulevard Investments (“GBI”), a licensed and fully compliant California based cannabis distribution and manufacturing company and a wholly owned subsidiary of Imaging3, Inc. (OTCQB: IGNG) (collectively “Grapefruit”), this morning announced that it has filed Amendment No. 1 to its Registration Statement on Form S-1 that was originally filed on July 28, 2019 regarding conversions of convertible notes issued to the company’s institutional investor Auctus Fund, LLC. “We are very pleased to file the Amendment which puts us back on track to complete the Auctus transaction. Pursuant to the terms of our Agreements with Auctus, immediately upon effectiveness of the Registration Statement, which we believe should occur in late February of 2020 we will receive a new Convertible Note Tranche of $750,000.00 from Auctus and 90 days later a final Convertible Note Tranche of $1,000,000.00. These funds are key to our revenue growth in 2020. In addition, as our common stock price increases in the future, we will be able to call warrants to bring in additional working capital. We are currently focused on ramping up revenues to justify an increased stock price which will afford us the opportunity to call the Warrants. We are also in the process of evaluating other capital raising possibilities. We feel we have regained our momentum which was temporarily slowed by the delay in the Grapefruit Boulevard Investment audit and look forward to 2020 and the myriad possibilities the future holds for Grapefruit,” Grapefruit CEO Bradley J. Yourist stated in the news release.

To view the full press release, visit http://cnw.fm/DEBv5

About Grapefruit Boulevard Investments Inc.

Grapefruit is a wholly-owned subsidiary of Imaging3, Inc. Grapefruit’s corporate headquarters is in Westwood, Los Angeles, California. Grapefruit holds California permits and licenses to both manufacture and distribute cannabis products. Grapefruit’s extraction laboratory and distribution facilities are located in the industry recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Rd., approximately 14 miles north of downtown Palm Springs. Grapefruit obtained its California cannabis licenses in January 2018 and commenced distribution of cannabis products thereafter. Grapefruit’s vision is to become a seed to sale, fully vertically integrated ethical and compliant cannabis company. For more information, visit the company’s website at www.Grapefruitblvd.com.

NOTE TO INVESTORS: The latest news and updates relating to IGNG are available in the company’s newsroom at http://cnw.fm/IGNG

About CannabisNewsWire

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW – Missouri Judge Orders Delay in Issuing Medical Marijuana Dispensary License

On Friday evening, the Missouri Department of Health and Senior Services was ordered by a court in Missouri to delay the approval or rejection of one applicant who had applied for a license to run a medical marijuana dispensary.

According to the statement previously issued by the Health Department, the permits would enable businesses located in secure areas to sell medical cannabis to patients. The Department expected to issue a minimum of 192 licenses within the state by January 24.

Judge Daniel Green, with the Cole County Circuit Court, ordered the delay of approval or rejection of one applicant for a license in Independence until a week (Jan.27) after the initial decision date.

It is not yet clear how the delay will affect the whole licensing process. When asked about the court order on Saturday morning, a DHSS spokeswoman said via a text message that the case is not about DHSS, but about the Independence ordinance. She further said that she does believe that the process would be delayed but asked them to refer their questions to the Office of the Attorney General in Missouri.

No response was issued by the spokesman for the attorney general when contacted for a comment.

At the beginning of last week, the USA TODAY Network reported that in 2019, Independence approved cannabis zoning rules were stricter than the barriers in churches, daycares, and schools that are written in the state-level medical cannabis constitutional amendment.

A former owner of a marijuana clinic that specialized in patients seeking state-approved medical marijuana cards Emily Branch said that supporters of marijuana regard Independence zoning rules as a violation of the Missouri constitution.

According to public records, the plaintiff, in this suit is the HCKC LLC, which is operating as Healing Center of Kansas City.

One of the officials of the Healing Center, Jay Richards, said that the company would not issue any statement at the time, but maybe after the state awards them the dispensary permit.

According to the medical marijuana dispensary applicant record provided by the Missouri Department of Health, there were other companies tied to Healing Center that applied for at least ten licenses.

Healing Center retail outlets would be spread across the state to St. Louis, Kansas City areas, Rolla, and Columbia.

Lying at the center of the lawsuit is the dispensary to be opened in the Kansas City Area, which is the hometown of President Harry Truman.

The suit’s defendants include the City of Independence, Department of Health and Senior Services, and its director Randal Williams, and they are using the same lawyer for their defense.

Another lawsuit was filed against the DHSS by the Sarcoxie Nurseries Tree Farm, who were denied a commercial cultivation license. At the beginning of January, the owner of Medigro LLC, Brian Atchley, said that he is tied to the two lawsuits. And like many other permit applicants, Atchley is questioning the DHSS licensing protocols.

Industry experts say such lawsuits can potentially derail the roll-out of the marijuana program, and they are certain that industry actors like No Borders Inc. (OTC: NBDR) wouldn’t want such a barrier to persist for long.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW – Oregon Report Shows Recreational Weed Sales Are Highest Along Idaho Border

The Oregon Office of Economic Analysis released a report which showed that marijuana sales are most substantial along the Oregon border with Idaho. It is noteworthy that recreational marijuana is illegal in the state of Idaho, so residents who wish to consume it have to buy it from Oregon.

According to the report which was issued on Friday, adult marijuana sales along the border of Oregon and Idaho are 420% the statewide average, wrote Josh Lehner of the Oregon Office of Economic Analysis. It is ironical that the percentage is 420 since that also happens to be the colloquial term for weed!

Along the Borders of Idaho and Washington, Lehner also found that marijuana sales were high. Recreational marijuana is legal in Washington.

Lehner further wrote that marijuana sales along the cities neighboring Idaho were stronger than he had anticipated. Recreational marijuana is illegal in the state of Idaho; however, after using a tax model to account for incomes, number of retailers, and tax rates, they found that there was a vast border effect.

A border effect occurs when two neighboring states have different rules, which prompt the residents of one jurisdiction to travel to the other in order to experience and take advantage of the different regulations in the other state. For instance, residents of Idaho traveling to Oregon to consume recreational marijuana. Another example is where the residents of Southwest Washington travel to Oregon to buy products on which no sales tax is levied.

In the U.S., Idaho is one of the few states without a law regulating medical marijuana, said the Marijuana Policy Project. Marijuana advocates working with the Idaho Cannabis Coalition and supporters, are collecting signatures to legalize medical marijuana within the state. This will make it possible for the residents of Idaho to legalize medical marijuana through a ballot initiative in November.

Lerner also forecasted that if the border effects persist in the next ten years, Oregon is going to experience rapid growth in marijuana sales.

Lehner further wrote that his office predicts that during the next ten years, the state’s marijuana sales are going to increase as incomes increase, the population within the state also increases, and as the stigma surrounding marijuana dies and the consumption rate rises.

The petition for gathering signatures was approved in August of 2019, and the advocates and supporters must collect more than 55,000 signatures within the state of Idaho to qualify for the 2020 ballot. April 30, 2020, is the deadline for signature collection.

After filing the petition, the leader of the campaign, Bill Esbensen, said that people should not suffer because they live in the wrong state. He also noted that the medical marijuana initiative is to bring Idaho up to par with other states where medical marijuana is legal such as Oklahoma, Arkansas and West Virginia. This will enable patients to treat their medical conditions with a non-toxic plant.

Analysts believe that weed companies like SinglePoint Inc. (OTCQB: SING) may be thinking that Oregon marijuana companies are getting some respite from the glut as a result of the border effect and this buys them some more time to build a bigger customer base within the state.

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Namaste Technologies Inc.’s (TSX.V: N) (OTCQB: NXTTF) Position to Capitalize on Changing Cannabis Industry Highlighted in technical420 Article

Namaste Technologies (TSX.V: N) (OTCQB: NXTTF), an online platform for cannabis products, accessories, and responsible education, was highlighted in a recent article by Anthony Varrell on technical420 titled ‘Namaste Technologies Is On Track To Be One Of The Biggest Turnaround Stories of 2020’. Among other highlights, the article discusses some recent key achievements by the company as well as its strategy moving forward. “Through CannMart, Namaste is well positioned to capitalize on the cannabis 2.0 opportunity, and we find this to be significant. The company expects to start selling several new cannabis derivative products in March and to submit up to 11 unique product SKUs to Health Canada for approval,” author Anthony Varrell states in the article. “The new product formats will be available on CannMart.com and offered through provincial cannabis stores in authorized markets.”

To view the full article, visit http://cnw.fm/doZY0

About Namaste Technologies

Namaste Technologies is the world’s leading online platform for cannabis products, accessories, and responsible education. The company is comprised of a number of wholly owned subsidiaries that could present significant upside and we are favorable on value creation that Namaste could deliver through this portfolio. CannMart represents one of the most important aspects of the Namaste story and the company believes that the market does not fully appreciate the value associated with this opportunity. CannMart provides customers with a diverse selection of hand-picked products from leading Canadian Licensed Producers (LPs). For more information, visit www.NamasteTechnologies.com.

About CanadianCannabisWire

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

HempNewsBreaks – Youngevity International Inc.’s (NASDAQ: YGYI) Khrysos Industries, Inc. Secures $1.2M of Tolling Revenue for February

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and a commercial hemp enterprise, together with its wholly owned subsidiary, Khrysos Industries, Inc., today announced that its tolling operation within its 82,000 square foot facility in Orlando, Florida has filled 42% of its available capacity generating $1.2 million of revenue for February tolling production. According to the update, Khrysos Industries tolling operation represents one revenue segment of Youngevity’s hemp enterprise. “Our current capacity for our tolling operations, at current prices, provides us the opportunity to generated monthly revenue of approximately $3 million per month,” YGYI President and CFO Dave Briskie said in the news release. “Currently, we are seeing strong demand for tolling of crude oil and we anticipate that this will continue throughout 2020. We remain committed to our hemp enterprise and its fully vertical capabilities in ingredient production, tolling, extraction and processing equipment sales, and finished goods and packaging.”

To view the full press release, visit http://cnw.fm/dL6hT

About Youngevity International, Inc.

YGYI, Inc. (NASDAQ: YGYI), is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model, that also offers e-commerce and the power of social selling. Assembling a virtual Main Street of products and services under one corporate entity, YGYI offers products from the eight top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, photo, as well as innovative services. The Company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution(R) Coffee Company (now part of the company’s food and beverage division). The resulting company became Youngevity International, Inc. in July 2013. For more information, visit the company’s website at www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://cnw.fm/YGYI

About HempWireNews

HempWireNews (HWN) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HNW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWireNews (HWN) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWireNews.com

Please see full terms of use and disclaimers on the HempWireNews website applicable to all content provided by HNW, wherever published or re-published: https://www.HempWireNews.com/Disclaimer

Do you have a questions or are you interested in working with HWN? Ask our Editor

HempWireNews (HWN)
Denver, Colorado
www.HempWireNews.com
303.498.7722 Office
Editor@HempWire.net

HempWireNews is part of the InvestorBrandNetwork.